Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with <i>KCNT1</i> Genetic Variants

Quinidine (QND) is an old antimalarial drug that was used in the early 20th century as an antiarrhythmic agent. Currently, QND is receiving attention for its use in epilepsy of infancy with migrating focal seizures (EIMFS) due to potassium sodium-activated channel subfamily T member 1 (<i>KCNT...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Alessandro Ferretti, Raffaele Simeoli, Sara Cairoli, Nicola Pietrafusa, Marina Trivisano, Carlo Dionisi Vici, Nicola Specchio, Bianca Maria Goffredo
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	therapeutic drug monitoring (TDM) quinidine pediatric patients KCNT1 DEE seizures
Online Access:	https://www.mdpi.com/1999-4923/14/10/2230

Similar Items

Two South Indian children with KCNT1-related malignant migrating focal seizures of infancy – Clinical characteristics and outcome of targeted treatment with quinidine
by: Abhijit Anil Patil, et al.
Published: (2019-01-01)

Efficacy of Anti-seizure Medications, Quinidine, and Ketogenic Diet Therapy for KCNT1-Related Epilepsy and Genotype-Efficacy Correlation Analysis
by: Zehong Lin, et al.
Published: (2022-01-01)

Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review
by: Yu Jia, et al.
Published: (2019-02-01)

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review
by: Fengji Cui, et al.
Published: (2024-03-01)

Coupling of Slack and NaV1.6 sensitizes Slack to quinidine blockade and guides anti-seizure strategy development
by: Tian Yuan, et al.
Published: (2024-01-01)

KCNT1 Channel Blockers: A Medicinal Chemistry Perspective
by: Francesca Di Matteo, et al.
Published: (2024-06-01)

APUNTE HISTÓRICO SOBRE LA QUINIDINA / A historical outline of quinidine
by: Margarita Dorantes Sánchez
Published: (2013-10-01)

Quinidine: an “Endangered Species” Drug Appropriate for Management of Electrical Storm in Brugada Syndrome
by: Stelios Paraskevaidis, MD, PhD, et al.
Published: (2013-09-01)

Electrical storm in an acquired short QT syndrome successfully treated with quinidine
by: Michael Spartalis, et al.
Published: (2019-08-01)

Long-term follow-up of vagus nerve stimulation in drug-resistant KCNT1-related epilepsy: a case presentation
by: Meng Wang, et al.
Published: (2022-11-01)

Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series
by: Francesca Tortora, et al.
Published: (2022-05-01)

Emerging Role of the KCNT1 Slack Channel in Intellectual Disability
by: Grace E. Kim, et al.
Published: (2014-07-01)

Rational quinidine dosage regimen for atrial fibrillation in Thoroughbred racehorses based on population pharmacokinetics
by: Taisuke Kuroda, et al.
Published: (2024-10-01)

Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
by: Wang Q, et al.
Published: (2019-12-01)

The case for quinidine: Management of electrical storm in refractory ventricular fibrillation
by: Rebecca Pinnelas, MD, et al.
Published: (2020-07-01)

Comparison between Inhibition of CatSper and KSper Channels with NNC 55-0396 and Quinidine on Human Sperm Function
by: Ali Asghar Zarei, et al.
Published: (2025-03-01)

Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients
by: Alessandro Mancini, et al.
Published: (2025-07-01)

Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons
by: Amy N Shore, et al.
Published: (2024-10-01)

Severe <i>KCNT1</i>-related developmental and epileptic encephalopathy
by: A. G. Malov, et al.
Published: (2025-07-01)

Synchronous heart rate reduction with suppression‐burst pattern in KCNT1‐related developmental and epileptic encephalopathies
by: Kaoru Yamamoto, et al.
Published: (2023-06-01)

Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine‐Independent and Chronic Itch
by: Annika Balzulat, et al.
Published: (2024-04-01)

Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy
by: Ilaria Mosca, et al.
Published: (2024-04-01)

A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy
by: Xie Na, et al.
Published: (2021-09-01)

Exploring the Role of the KCNK1 Potassium Channel and Its Inhibition Using Quinidine in Treating Head and Neck Squamous Cell Carcinoma
by: Hyun Woo Baek, et al.
Published: (2024-11-01)

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
by: Sophie F. Hill, et al.
Published: (2023-10-01)

Molecular Profiling of Mouse Models of Loss or Gain of Function of the KCNT1 (Slack) Potassium Channel and Antisense Oligonucleotide Treatment
by: Fangxu Sun, et al.
Published: (2024-11-01)

In vitro evaluation of quinidine sensitivity in brazilian Plasmodium falciparum isolates: comparative analysis to quinine and chloroquine Avaliação da sensibilidade in vitro à quinidina em isolados brasileiros de Plasmodium falciparum: análise comparativa à quinina e à cloroquina
by: Carla M. S. MENEZES, et al.
Published: (2001-08-01)

Case report: A young man with non-rapid eye movement parasomnias in a KCNT1-related epilepsy family
by: Dandan Sheng, et al.
Published: (2023-11-01)

Use of Antibiotics in Preterm Newborns
by: Raffaele Simeoli, et al.
Published: (2022-08-01)

Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?
by: Nicola Pietrafusa, et al.
Published: (2023-12-01)

The economic burden of KCNT1-related disorders in the United States: insights from caregiver-reported and EMR-derived data
by: Amanda Abuhl, et al.
Published: (2026-04-01)

Impact of Continuous Kidney Replacement Therapy and Hemoadsorption with CytoSorb on Antimicrobial Drug Removal in Critically Ill Children with Septic Shock: A Single-Center Prospective Study on a Pediatric Cohort
by: Gabriella Bottari, et al.
Published: (2023-08-01)

Italian report on RARE epilepsies (i‐RARE): A consensus on multidisciplinarity
by: Antonella Riva, et al.
Published: (2024-10-01)

Measurement of Anti-TNF Biologics in Serum Samples of Pediatric Patients: Comparison of Enzyme-Linked Immunosorbent Assay (ELISA) with a Rapid and Automated Fluorescence-Based Lateral Flow Immunoassay
by: Chiara Rossi, et al.
Published: (2025-03-01)

Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
by: Srinivasarao Repudi, et al.
Published: (2021-11-01)

A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures
by: Rían W. Manville, et al.
Published: (2024-10-01)

Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
by: Camerin C. Passey, PharmD, MBA, et al.
Published: (2019-01-01)

A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients
by: Raffaele Simeoli, et al.
Published: (2024-05-01)

Therapeutic drug monitoring of lacosamide among children: is it helpful?
by: Elkana Kohn, et al.
Published: (2023-07-01)

A machine learning-based high-precision density functional method for drug-like molecules
by: Jin Xiao, et al.
Published: (2024-06-01)